Affimed Touts Encouraging Patient Responses For Its NK Cell Therapy In Lymphoma Settings
Affimed N.V. (NASDAQ: AFMD)
Benzinga ·
Get all your news in one place.
100's of premium titles.
One app.
Start reading
One app.
Get all your news in one place.
100's of premium titles. One news app.
FOUND: Afmd - What They Never Told You
Recap: Affimed Q4 Earnings
Affimed (NASDAQ:AFMD) reported its Q4 earnings results on Thursday, March 31, 2022 at 08:00 AM.
Here's what investors need to know about the announcement.
Benzinga ·
From analysis to the latest developments in health,
read the most diverse news in one place.
read the most diverse news in one place.
Coverage From
Benzinga
Organisations
From analysis to the latest developments in health,
read the most diverse news in one place.
read the most diverse news in one place.
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.
100+ trusted global sources.
